

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $161.05
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 12, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Oct 7, 26 | UBS | maintain | Buy | Buy |
| Oct 6, 26 | JP Morgan | maintain | Overweight | Overweight |
| Oct 6, 26 | Barclays | maintain | Overweight | Overweight |
| Oct 5, 26 | Morgan Stanley | downgrade | Overweight | Equal Weight |
| Sep 21, 26 | Citigroup | maintain | Buy | Buy |
| Aug 11, 26 | Argus Research | maintain | Buy | Buy |
| Aug 10, 26 | Stephens & Co. | maintain | Equal Weight | Equal Weight |
| Aug 7, 26 | Morgan Stanley | maintain | Overweight | Overweight |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 44.65 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 41.54 | Oscillator | Neutral |
| Williams %R (14) | -43.72 | Oscillator | Neutral |
| MACD (12, 26, 9) | -5.56 (Hist 1.88) | Oscillator | Buy |
| Average Directional Index (14) | 31.15 (+DI 13.2 / -DI 24.4) | Trend | Strong Sell |
| EMA 20 | 162.50 | MA | Sell |
| SMA 20 | 158.86 | MA | Buy |
| EMA 50 | 174.86 | MA | Strong Sell |
| SMA 50 | 180.34 | MA | Strong Sell |
| SMA 200 | 194.81 | MA | Strong Sell |
FY2025 · 10-K disclosure
FY2011 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 13, 26 | Stewart Mark Wynn | director | 0 | — | |
| Oct 13, 26 | Stewart Mark Wynn | director: | 0 | — | |
| Aug 7, 26 | Szlosek Thomas A | officer: EVP & CFO | M-Exempt | 3,194 | — |
| Aug 7, 26 | Szlosek Thomas A | officer: EVP & CFO | F-InKind | 1,257 @ $209.23 | $263.0K |
| Aug 7, 26 | Szlosek Thomas A | officer: EVP & CFO | M-Exempt | 3,194 | — |
| Aug 5, 26 | Lutoff-Perlo Lisa | director | S-Sale | 900 @ $220.00 | $198.0K |
| May 5, 26 | Dees Kimberly | officer: SVP & CAO | S-Sale | 2,500 @ $204.91 | $512.3K |
| Mar 1, 26 | Szlosek Thomas A | officer: EVP & CFO | M-Exempt | 1,900 | — |
TTM vs. 5-year historical average (annual ratios)
| Metric | AN | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 7.3x | 7.9x · sector 73.6x | Discount |
| Forward P/E (FY26E) | 7.7x | EPS est. 20.89 | In line |
| Price / Book | 2.4x | 3.1x | Discount |
| Price / Sales | 0.2x | 0.3x | Discount |
| EV / EBITDA | 10.1x | 8.1x | Elevated |
| Return on equity | 33.2% | — | Top tier |
| Gross margin | 17.8% | 18.7% | In line |
| Debt / Equity | 5.02 | 3.35 | Levered |
| Piotroski / Altman Z | 4/9 | Z 2.78 | Grey zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 3/A | Oct 21, 2026 | 2026-10-21 16:18:11 | View |
| 3 | Oct 16, 2026 | 2026-10-16 08:33:04 | View |
| 8-K | Oct 16, 2026 | 2026-10-16 08:31:57 | View |
| SC 13G | Oct 2, 2026 | 2026-10-02 11:47:32 | View |
| 8-K | Sep 15, 2026 | 2026-09-15 16:15:31 | View |
| 4 | Aug 10, 2026 | 2026-08-10 18:02:07 | View |
| 4 | Aug 7, 2026 | 2026-08-07 16:07:34 | View |
| 10-Q | Jul 31, 2026 | 2026-07-31 16:32:29 | View |
| 8-K | Jul 31, 2026 | 2026-07-31 07:01:35 | View |
| 4 | May 7, 2026 | 2026-05-07 16:30:17 | View |
Proxy statement (DEF 14A) disclosures
Stock news · updated daily
AutoNation (AN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbbVie Announces Topline Results from the Phase 3 INTREPID Trial Showing Lutikizumab Significantly Improved Signs and Symptoms of Disease in Patients with Hidra
Shares of AutoNation, Inc. (NYSE: AN - Get Free Report) were up 6.7% on Friday. The company traded as high as $163.47 and last traded at $163.5190. 17,940 shares changed hands during trading, a decline of 96% from the average session volume of 448,400 shares. The stock had previously closed at $153.19. Analyst Upgrades and Downgrades
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AutoNation, Inc. (NYSE: AN), one of the largest automotive retailers in the United States, today announced the appointment of Mark Stewart to its Board of Directors as an independent director. “Mark is a proven global leader with deep experience across the automotive, manufacturing, technology, and consumer sectors,” said Rick Burdick, Chairman of the AutoNation Board of Directors. “His strategic perspective, operational discipline, and track record of le.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AutoNation, Inc. (NYSE: AN), today announced that it will release its financial results for the third quarter ended September 30, 2026, on Friday, October 30, 2026, before the market opens. AutoNation management will discuss these results and other information regarding the Company during a conference call and audio webcast that same day at 9:00 a.m. Eastern Time. The conference call may be accessed by telephone at 833-461-5787 (Conference ID: 561396341).
A Concentrated Bet on Auto Retail On Sept. 30, 2026, Glenn Greenberg (Trades, Portfolio) executed a purchase of 402,303 shares of AutoNation Inc (AN) at a price
Wall Street kicked off the first full week of Q4 2026 with a flurry of bold analyst moves, including a sweeping Microsoft upgrade and a brutal Align Technology target slash. Find out which names got upgraded, downgraded, or freshly initiated before the opening bell.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AutoNation, Inc. (NYSE: AN) today announced the appointment of Ravi Simhambhatla as Chief Technology and AI Officer, effective October 1, 2026. Mr. Simhambhatla will lead the Company's technology, data science, and AI agenda. "Over decades, we have built a portfolio of brands, physical infrastructure, and scale that have delivered consistently strong returns for our shareholders, and that would be nearly impossible to replicate today," said Mike Manley, C.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Jul 31, 2026 | 5.48 | 5.56 | Beat 1.5% | $6.93B |
| May 1, 2026 | 4.51 | 4.69 | Beat 4.0% | $6.55B |
| Feb 6, 2026 | 4.85 | 5.08 | Beat 4.7% | $6.93B |
| Oct 23, 2025 | 4.85 | 5.01 | Beat 3.3% | $7.04B |
| Jul 25, 2025 | 4.70 | 5.46 | Beat 16.2% | $6.97B |
| Apr 25, 2025 | 4.42 | 4.68 | Beat 5.9% | $6.69B |